Intriguingly, hepatic overexpression of Gadd34, which encodes an eIF2α-specific phosphatase that selectively counteracts PERK-eIF2α action, results in improved insulin sensitivity and diminished hepatic steatosis on HFD [15]. Here, EIF2AK3 is linked to Hepatic steatosis.